Product

Altropane

Aliases

Altropane (123I) Injection

1 clinical trial

2 indications

Indication

Parkinson's disease

Indication

Movement Disorders

Clinical trial

An Open-label Multicenter Phase 2 Dose-evaluation Study of Altropane (123I) Injection for Striatal Dopamine Transporter Visualization Using SPECT Brain Imaging

Status: Recruiting, Estimated PCD: 2024-03-29